<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochem J</journal-id><journal-id journal-id-type="iso-abbrev">Biochem. J</journal-id><journal-id journal-id-type="pmc">bic</journal-id><journal-id journal-id-type="publisher-id">BJ</journal-id><journal-title-group><journal-title>Biochemical Journal</journal-title></journal-title-group><issn pub-type="ppub">0264-6021</issn><issn pub-type="epub">1470-8728</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3924758</article-id><article-id pub-id-type="publisher-id">BJ20131405</article-id><article-id pub-id-type="doi">10.1042/BJ20131405</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The inhibition of functional expression of calcium channels by prion protein demonstrates competition with &#945;<sub>2</sub>&#948; for GPI-anchoring pathways</article-title><alt-title alt-title-type="right-running-head">Functional interaction between prion protein and &#945;<sub>2</sub>&#948;</alt-title><alt-title alt-title-type="left-running-head">A. Alvarez-Laviada and others</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alvarez-Laviada</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="author-notes" rid="fn1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kadurin</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Senatore</surname><given-names>Assunta</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="author-notes" rid="fn2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chiesa</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="A2">&#8224;</xref></contrib><contrib contrib-type="author"><name><surname>Dolphin</surname><given-names>Annette&#160;C.</given-names></name><xref ref-type="aff" rid="A1">*</xref><xref ref-type="corresp" rid="COR1"><sup>3</sup></xref></contrib><aff id="A1">*Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, U.K.</aff><aff id="A2">&#8224;Dulbecco Telethon Institute c/o Department of Neuroscience, IRCCS&#8211;Istituto di Ricerche Farmacologiche &#8220;Mario Negri&#8221;, Milano, Italy</aff></contrib-group><author-notes><fn id="fn1" fn-type="present-address"><p><sup>1</sup>Present address: National Heart &amp; Lung Institute, Imperial College London, London W12 0NN, U.K.</p></fn><fn id="fn2" fn-type="present-address"><p><sup>2</sup>Present address: Institute of Neuropathology, Universit&#228;tsspit&#228;l Z&#252;rich, Schmelzbergstrasse 12, CH-8091 Z&#252;rich, Switzerland</p></fn><corresp id="COR1"><sup>3</sup>To whom correspondence should be addressed (email <email>a.dolphin@ucl.ac.uk</email>).</corresp></author-notes><pub-date pub-type="epreprint"><day>12</day><month>12</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>1</day><month>3</month><year>2014</year></pub-date><volume>458</volume><issue>Pt 2</issue><fpage>365</fpage><lpage>374</lpage><history><date date-type="received"><day>23</day><month>10</month><year>2013</year></date><date date-type="rev-recd"><day>19</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>&#169; 2014 The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY)(http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>It has been shown recently that PrP (prion protein) and the calcium channel auxiliary &#945;<sub>2</sub>&#948; subunits interact in neurons and expression systems [Senatore, Colleoni, Verderio, Restelli, Morini, Condliffe, Bertani, Mantovani, Canovi, Micotti, Forloni, Dolphin, Matteoli, Gobbi and Chiesa (2012) Neuron <bold>74</bold>, 300&#8211;313]. In the present study we examined whether there was an effect of PrP on calcium currents. We have shown that when PrP is co-expressed with calcium channels formed from Ca<sub>V</sub>2.1/&#946; and &#945;<sub>2</sub>&#948;-1 or &#945;<sub>2</sub>&#948;-2, there is a consistent decrease in calcium current density. This reduction was absent when a PrP construct was used lacking its GPI (glycosylphosphatidylinositol) anchor. We have reported previously that &#945;<sub>2</sub>&#948; subunits are able to form GPI-anchored proteins [Davies, Kadurin, Alvarez-Laviada, Douglas, Nieto-Rostro, Bauer, Pratt and Dolphin (2010) Proc. Natl. Acad. Sci. U.S.A. <bold>107</bold>, 1654&#8211;1659] and show further evidence in the present paper. We have characterized recently a C-terminally truncated &#945;<sub>2</sub>&#948;-1 construct, &#945;<sub>2</sub>&#948;-1&#916;C, and found that, despite loss of its membrane anchor, it still shows a partial ability to increase calcium currents [Kadurin, Alvarez-Laviada, Ng, Walker-Gray, D&#8217;Arco, Fadel, Pratt and Dolphin (2012) J. Biol. Chem. <bold>1287</bold>, 33554&#8211;33566]. We now find that PrP does not inhibit Ca<sub>V</sub>2.1/&#946; currents formed with &#945;<sub>2</sub>&#948;-1&#916;C, rather than &#945;<sub>2</sub>&#948;-1. It is possible that PrP and &#945;<sub>2</sub>&#948;-1 compete for GPI-anchor intermediates or trafficking pathways, or that interaction between PrP and &#945;<sub>2</sub>&#948;-1 requires association in cholesterol-rich membrane microdomains. Our additional finding that Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 currents were inhibited by GPI&#8211;GFP, but not cytosolic GFP, indicates that competition for limited GPI-anchor intermediates or trafficking pathways may be involved in PrP suppression of &#945;<sub>2</sub>&#948; subunit function.</p></abstract><abstract abstract-type="short"><p>PrP, but not GPI-anchorless PrP, suppresses Ca<sub>V</sub>2.1/&#946;/&#945;<sub>2</sub>&#948;-1 or &#945;<sub>2</sub>&#948;-2 calcium channel currents. However, PrP does not inhibit Ca<sub>V</sub>2.1/&#946; currents formed with anchorless &#945;<sub>2</sub>&#948;-1, rather than full-length &#945;<sub>2</sub>&#948;-1. The results of the present study suggest that &#945;<sub>2</sub>&#948; subunits and PrP may compete for GPI-anchor pathways.</p></abstract><kwd-group kwd-group-type="kwd"><kwd>&#945;<sub>2</sub>&#948;</kwd><kwd>auxiliary subunit</kwd><kwd>calcium channel</kwd><kwd>GPI anchor</kwd><kwd>prion protein</kwd></kwd-group><kwd-group kwd-group-type="abbr"><kwd>Ca<sub>V</sub>, voltage-gated Ca<sup>2+</sup></kwd><kwd>DRM, detergent-resistant membrane</kwd><kwd>GPI, glycosylphosphatidylinositol</kwd><kwd>HA, haemagglutinin</kwd><kwd>KO, knockout</kwd><kwd>MBS, Mes-buffered saline</kwd><kwd>PI-PLC, phosphatidylinositol-specific phospholipase C</kwd><kwd>PNGase F, peptide N-glycosidase F</kwd><kwd>PrP, prion protein</kwd><kwd>PrP<sup>C</sup>, normal cellular PrP</kwd><kwd>PrP<sup>Sc</sup>, PrP scrapie</kwd><kwd>WT, wild-type</kwd></kwd-group><counts><fig-count count="5"/><ref-count count="53"/><page-count count="10"/></counts></article-meta></front><body><sec><title>INTRODUCTION</title><p>Ca<sub>V</sub> (voltage-gated Ca<sup>2+</sup>) channels contain a pore-forming &#945;<sub>1</sub> subunit, which determines the main properties, both biophysical and pharmacological, of the channels. For the Ca<sub>V</sub>1 and Ca<sub>V</sub>2 subfamilies, the &#945;<sub>1</sub> subunit is associated with a membrane-anchored predominantly extracellular &#945;<sub>2</sub>&#948; subunit (for a review, see [<xref rid="B1" ref-type="bibr">1</xref>]) and a cytoplasmic &#946; subunit (for reviews, see [<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>]). The &#946; subunits have been shown to enhance calcium channel trafficking by binding to the I&#8211;II linker of the &#945;<sub>1</sub> subunits [<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>], and thus inhibiting proteasomal decay as has been shown for the Ca<sub>V</sub>2.2 [<xref rid="B6" ref-type="bibr">6</xref>] and Ca<sub>V</sub>1.2 [<xref rid="B7" ref-type="bibr">7</xref>] channels. In contrast, the mechanism of enhancement of the Ca<sub>V</sub> channel functional expression by &#945;<sub>2</sub>&#948; subunits has not been firmly established, although we have found that it involves their von Willebrand Factor A domain [<xref rid="B8" ref-type="bibr">8</xref>], and results in increased plasma membrane expression and active zone targeting of the channel complex [<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref>].</p><p>The major mechanism whereby &#945;<sub>2</sub>&#948; subunits increase the functional expression of calcium channels is due to an increase in the amount of channel protein at the plasma membrane ([<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B10" ref-type="bibr">10</xref>] and J.S. Cassidy and A.C. Dolphin, unpublished work). Furthermore, it has been found that the &#945;<sub>2</sub>&#948; subunits do not increase single channel conductance or open probability [<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>], two other mechanisms whereby macroscopic current could be increased. Nevertheless, there are effects of &#945;<sub>2</sub>&#948; subunits to increase voltage-dependent inactivation and to hyperpolarize the voltage-dependence of steady-state inactivation, providing evidence that these subunits do remain associated with the functional channel complex on the plasma membrane [<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>].</p><p>Mammalian genes encoding four &#945;<sub>2</sub>&#948; subunits have been identified (for reviews, see [<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B15" ref-type="bibr">15</xref>]). The topology of the &#945;<sub>2</sub>&#948; protein was first determined for &#945;<sub>2</sub>&#948;-1, and is thought to generalize to all four &#945;<sub>2</sub>&#948; subunits (for reviews, see [<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B16" ref-type="bibr">16</xref>]). They all have predicted N-terminal signal sequences, indicating that the N-terminus is extracellular. The &#945;<sub>2</sub> and &#948; subunits are the product of a single gene, encoding the &#945;<sub>2</sub>&#948; pre-protein, which is post-translationally cleaved into &#945;<sub>2</sub> and &#948; [<xref rid="B17" ref-type="bibr">17</xref>]. The extracellular &#945;<sub>2</sub> subunit then remains disulfide-bonded to the membrane-bound &#948; subunit. Although &#945;<sub>2</sub>&#948; subunits were originally described as transmembrane proteins, we have shown previously that they can form GPI (glycosylphosphatidylinositol)-anchored proteins [<xref rid="B13" ref-type="bibr">13</xref>].</p><p>The PrP<sup>C</sup> [normal cellular PrP (prion protein)] is a GPI-anchored sialoglycoprotein [<xref rid="B18" ref-type="bibr">18</xref>] exposed on the outer leaflet of the plasma membrane, that is widely distributed throughout the nervous system [<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>]. Its normal physiological function is still being elucidated [<xref rid="B20" ref-type="bibr">20</xref>] and genetic ablation of PrP KO (knockout) only produces subtle phenotypes in mice [<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>]. However, it appears to play a role in signal transduction [<xref rid="B23" ref-type="bibr">23</xref>], copper binding [<xref rid="B24" ref-type="bibr">24</xref>], synaptic function [<xref rid="B25" ref-type="bibr">25</xref>] and myelin maintenance [<xref rid="B26" ref-type="bibr">26</xref>]. Furthermore, misfolding of PrP<sup>C</sup> results in the formation of the partially protease-resistant isoform PrP<sup>Sc</sup> (PrP scrapie), which accumulates in the brain and results in neurodegeneration, giving rise to Creutzfeldt&#8211;Jakob disease [<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B27" ref-type="bibr">27</xref>]. PrP<sup>Sc</sup> is both neurotoxic and infectious. In the absence of PrP<sup>C</sup>, PrP<sup>Sc</sup> cannot be generated and PrP-null mice do not propagate infectivity or develop pathology on infection with PrP<sup>Sc</sup> [<xref rid="B28" ref-type="bibr">28</xref>&#8211;<xref rid="B30" ref-type="bibr">30</xref>]. Thus it has been postulated that the presence of PrP<sup>C</sup> in neurons is essential for the initiation of a cascade of signalling events leading to prion disease pathology.</p><p>Initial evidence that the &#945;<sub>2</sub>&#948; subunits are closely associated with PrP came from the finding that the &#945;<sub>2</sub>&#948;-1, &#945;<sub>2</sub>&#948;-2 and &#945;<sub>2</sub>&#948;-3 subunits were co-immunopurified with PrP from the brains of transgenic mice expressing Myc-tagged PrP [<xref rid="B31" ref-type="bibr">31</xref>]. The &#945;<sub>2</sub>&#948; subunits are expressed strongly in cholesterol-rich detergent-resistant membranes [<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B32" ref-type="bibr">32</xref>], as is PrP [<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>], which may represent the basis for their association. It has been shown recently that &#945;<sub>2</sub>&#948;-1 and PrP can co-immunoprecipitate from both brain tissue and cell lines [<xref rid="B35" ref-type="bibr">35</xref>], and that the interaction between pathogenic mutant PrP and &#945;<sub>2</sub>&#948;-1 results in the intracellular retention of both species [<xref rid="B35" ref-type="bibr">35</xref>].</p><p>We were interested to determine whether PrP co-expression has any direct effect on calcium channel currents via a direct or indirect effect on &#945;<sub>2</sub>&#948; subunit processing or function. We therefore utilized full-length and C-terminally truncated PrP and &#945;<sub>2</sub>&#948;-1 to examine the effect of these species on calcium channel functional expression.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Heterologous expression of cDNAs</title><p>The calcium channel cDNAs used were rat Ca<sub>V</sub>2.1 (GenBank&#174; accession number M64373), mouse &#945;<sub>2</sub>&#948;-2 (GenBank&#174; accession number AF247139), rat &#945;<sub>2</sub>&#948;-1 (GenBank&#174; accession number M86621), &#945;<sub>2</sub>&#948;-1 mid HA (haemagglutinin) [<xref rid="B36" ref-type="bibr">36</xref>], &#945;<sub>2</sub>&#948;-1&#916;C&#8211;HA [<xref rid="B36" ref-type="bibr">36</xref>], rat &#946;4 (GenBank&#174; accession number NM001105733) and rat &#946;1b [<xref rid="B37" ref-type="bibr">37</xref>]. The PrP constructs used (in pcDNA3) were WT (wild-type) PrP (mouse) and &#916;GPI&#8211;PrP [<xref rid="B38" ref-type="bibr">38</xref>]. The GFP constructs used were mut3 GFP [<xref rid="B39" ref-type="bibr">39</xref>] and GPI&#8211;GFP in pcDNA3 [<xref rid="B40" ref-type="bibr">40</xref>]. The cDNAs were in the pMT2 expression vector, unless stated above. Mammalian tsA-201 cells were transfected with the following cDNA combinations (Ca<sub>v</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1/PrP at 3:2:2:0.5 or Ca<sub>v</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/PrP at 3:2:2:1), with empty vector replacing constructs not used unless otherwise stated, and transfection was performed as described previously [<xref rid="B41" ref-type="bibr">41</xref>]. The cDNA for GFP was also included to identify transfected cells from which electrophysiological recordings and imaging were performed, unless GPI&#8211;GFP was used.</p></sec><sec><title>Mice</title><p>Cerebella were obtained from C57BL/6J (WT) mice or from Tg(WT-E1) mice expressing WT mouse PrP with an epitope for the monoclonal antibody 3F4 at approximately 4-fold the endogenous PrP level, referred to throughout the text as PrP Tg(WT) [<xref rid="B42" ref-type="bibr">42</xref>], or from PrP-KO mice with a pure C57BL/6J background (European Mouse Mutant Archive, Monterotondo, Rome; EM:01723) [<xref rid="B21" ref-type="bibr">21</xref>].</p></sec><sec><title>Preparation of Triton X-100-insoluble membrane fractions [DRMs (detergent-resistant membrane)]</title><p>All steps were performed on ice. One cerebellum was used as the starting material from WT, PrP Tg(WT) and PrP-KO mice. The cerebella were homogenized using a Teflon homogenizer in MBS [Mes-buffered saline; 25 mM Mes (pH&#160;6.5), 150&#160;mM NaCl and Complete&#8482; protease inhibitor cocktail (Roche)], containing 1% (v/v) Triton X-100 (Thermo Scientific), and left on ice for 1&#160;h. An equal volume of 90% (w/v) sucrose in MBS was then added. The sample was transferred into a 13&#160;ml ultracentrifuge tube and overlaid with 10&#160;ml of discontinuous sucrose gradient, consisting of 35% (w/v) sucrose in MBS (5&#160;ml) and 5% (w/v) sucrose in MBS (5&#160;ml). The sucrose gradients were centrifuged at 138000 <bold><italic>g</italic></bold> for 18&#160;h at 4&#176;C (Beckman SW40 rotor). Fractions (1&#160;ml) were subsequently harvested from the top to the bottom of the tube. When necessary, protein fractions from the gradient were washed free of sucrose by dilution in 25 volumes of ice-cold PBS and ultracentrifugation (150000&#160;<bold><italic>g</italic></bold> for 1&#160;h at 4&#176;C) to pellet the cholesterol-enriched microdomain material. Triton X-100-insoluble protein was resuspended in deglycosylation buffer and treated with PNGase F (peptide N-glycosidase F; Roche), as described below.</p></sec><sec><title>Treatment of Triton X-100-insoluble protein fractions with PI-PLC (phosphatidylinositol-specific phospholipase C)</title><p>Triton X-100-insoluble fractions from brain tissue were collected, washed free of sucrose and centrifuged as described above. The resultant pellet of Triton X-100-insoluble material was resuspended in an appropriate volume of PI-PLC reaction buffer [10&#160;mM Tris/HCl (pH&#160;7.4) and 150&#160;mM NaCl containing Complete&#8482; protease inhibitor cocktail (Roche)], to a final protein concentration of ~2&#160;mg/ml. The samples were sonicated and treated with 25&#160;units of PI-PLC enzyme (Sigma) for 3&#160;h at 37&#176;C.</p></sec><sec><title>Phase separation of PI-PLC-treated proteins using Triton X-114</title><p>Membrane-associated proteins were separated from soluble proteins in two phases of Triton X-114 as described previously [<xref rid="B43" ref-type="bibr">43</xref>]. Briefly, the pellet of detergent-insoluble material was resuspended in an appropriate volume of reaction buffer (final concentration of ~2&#160;mg/ml of protein) and incubated with PI-PLC as described above. Control experiments omitting the enzyme were also performed. After PI-PLC incubation the samples were supplemented with Triton X-114 (Thermo Scientific) to a final concentration of 1%. A cushion of 6% (w/v) sucrose, 10&#160;mM Tris/HCl (pH&#160;7.4), 150&#160;mM NaCl and 0.06% Triton X-114 was placed at the bottom of a 1.5&#160;ml Eppendorf tube. The protein sample was then overlaid on this sucrose cushion and the tube incubated for 3&#160;min at 30&#176;C and centrifuged at 300&#160;<bold><italic>g</italic></bold> for 4&#160;min at room temperature (20&#176;C) in a swinging bucket rotor. Following centrifugation, the detergent phase was present as an oily droplet at the bottom of the tube. Fresh Triton X-114 was then added to the upper aqueous phase to 0.5% and the procedure was repeated using the same sucrose cushion. In the last step the aqueous phase was removed from the cushion, supplemented with fresh Triton X-114 to 2% and subjected to another centrifugation. The detergent phase of this last procedure was discarded. The aqueous and detergent phases from this procedure were adjusted to the equal volume with 10&#160;mM Tris/HCl (pH&#160;7.4) and 150&#160;mM NaCl plus protease inhibitors.</p></sec><sec><title>Acetone precipitation and PNGase F deglycosylation</title><p>To remove the remaining Triton X-114&#160;in the detergent and aqueous phases from the phase separation experiment the proteins were precipitated by the addition of 4 volumes of ice-cold acetone and subsequent incubation for 1&#160;h at &#8722;20&#176;C. The precipitated material was centrifuged at 16000&#160;<bold><italic>g</italic></bold> for 10&#160;min and the pellet was washed once with an acetone/water (4:1) mixture (&#8722;20&#176;C). The pellets of the precipitated proteins were then resuspended in 45&#160;&#956;l of PNGase F buffer [10&#160;mM Tris/HCl (pH&#160;7.5) and 150&#160;mM NaCl supplemented with 75&#160;mM 2-mercaptoethanol, 0.5% Triton X-100, 0.1% SDS and protease inhibitors]. A total of 1&#160;unit of PNGase F was added per 10&#160;&#956;l volume followed by incubation at 37&#176;C for 5&#8211;12&#160;h. The samples were then resuspended in an appropriate volume of SDS gel loading buffer and heated for 10&#160;min at 56&#176;C in order to terminate the reaction.</p></sec><sec><title>Immunoblotting</title><p>Western blotting was performed as described previously [<xref rid="B41" ref-type="bibr">41</xref>]. The samples were resolved on either 3&#8211;8% Tris/acetate or 4&#8211;12% Bis-Tris gels with the relevant buffer systems (Life Technologies). The samples were then blotted on to PVDF membranes (Bio-Rad Laboratories), blocked with 3% BSA in TBS provided with 0.5% Igepal and incubated with the following primary antibodies: anti-&#945;<sub>2</sub>-1 (1:1000 dilution; mouse monoclonal; Sigma), anti-&#945;<sub>2</sub>-2 (residues 102&#8211;117; rabbit polyclonal; [<xref rid="B44" ref-type="bibr">44</xref>]), anti-PrP (3F4 epitope), anti-PrP (residues 45&#8211;66; rabbit polyclonal; [<xref rid="B45" ref-type="bibr">45</xref>]) and anti-flotillin-1 (1:2000 dilution; mouse monoclonal; BD Biosciences). The secondary antibodies used were goat anti-mouse and goat anti-rabbit coupled to HRP (horseradish peroxidase; Bio-Rad Laboratories).</p></sec><sec><title>Electrophysiology</title><p>Calcium channel expression in tsA-201 cells was investigated by whole-cell patch-clamp recording essentially as described previously [<xref rid="B46" ref-type="bibr">46</xref>]. The internal (pipette) and external solutions and recording techniques were similar to those described previously [<xref rid="B47" ref-type="bibr">47</xref>]. The patch pipette solution contained: 140&#160;mM caesium aspartate, 5&#160;mM EGTA, 2&#160;mM MgCl<sub>2</sub>, 0.1&#160;mM CaCl<sub>2</sub>, 2&#160;mM K<sub>2</sub>-ATP and 10&#160;mM Hepes, pH&#160;7.2 at 310&#160;mM mOsm, with sucrose. The external solution for recording Ba<sup>2+</sup> currents contained: 150&#160;mM tetraethylammonium Br, 3&#160;mM KCl, 1&#160;mM NaHCO<sub>3</sub>, 1&#160;mM MgCl<sub>2</sub>, 10&#160;mM Hepes, 4&#160;mM glucose and 1&#160;mM BaCl<sub>2</sub>, pH&#160;7.4 at 320 mOsm, with sucrose. Pipettes of resistance 2&#8211;4&#160;M&#937; were used. An Axopatch 1D amplifier (Axon Instruments) was used, and data were filtered at 1&#8211;2 kHz and digitized at 5&#8211;10 kHz. Current records were subjected to leak and residual capacitance current subtraction (P/8 protocol). Analysis was performed using Pclamp 9 (Molecular Devices) and Origin 7 (Microcal Origin). All comparisons between different groups of transfected cells were performed in parallel on the same experimental days.</p><p>When stated, current&#8211;voltage (<italic>I</italic>&#8211;<italic>V</italic>) plots were fit with a modified Boltzmann equation for determination of the voltage for 50% activation (<italic>V</italic><sub>50</sub>, activation) [<xref rid="B48" ref-type="bibr">48</xref>], and steady-state inactivation curves were fit with a single Boltzmann function for determination of the voltage for 50% inactivation (<italic>V</italic><sub>50</sub>, inactivation). Where data are given as means&#177;S.E.M., statistical comparisons were performed using either Student's <italic>t</italic> test or ANOVA with the appropriate post-hoc test.</p><p><italic>Xenopus</italic> oocytes were prepared, injected and utilized for electrophysiology as described previously [<xref rid="B49" ref-type="bibr">49</xref>], with the following exceptions. Plasmid cDNAs for the calcium channel &#945;1, &#945;<sub>2</sub>&#948;-1 and &#946;1b subunits and for PrP were mixed at 2:1:2:x ratios at 1&#160;&#956;g/&#956;l, where x=2, 1 or 0.5 unless otherwise stated, and the empty vector was included to maintain the total cDNA mixture constant. A 9 nl volume was injected intranuclearly, after 2-fold dilution of the cDNA mixtures. Recordings in <italic>Xenopus</italic> oocytes were performed at 18&#176;C as described previously [<xref rid="B48" ref-type="bibr">48</xref>], and all recordings were performed 48&#8211;60&#160;h after injection for Ca<sub>V</sub>2.2. The Ba<sup>2+</sup> concentration was 10&#160;mM.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>&#945;<sub>2</sub>&#948; subunits and PrP show similar biochemical properties</title><p>We have shown previously that endogenous &#945;<sub>2</sub>&#948;-1 and &#945;<sub>2</sub>&#948;-2 are strongly expressed in DRM fractions [<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B32" ref-type="bibr">32</xref>], as is PrP [<xref rid="B18" ref-type="bibr">18</xref>]. Therefore we prepared DRM fractions from the cerebella of WT, PrP Tg(WT) and PrP-KO mice. We found the typical localization of &#945;<sub>2</sub>&#948;-1, &#945;<sub>2</sub>&#948;-2 and also PrP in DRMs (<xref ref-type="fig" rid="F1">Figure 1</xref>A).</p><fig id="F1" position="float"><label>Figure 1</label><caption><title>PI-PLC treatment and phase separation of &#945;<sub>2</sub>&#948;-1, &#945;<sub>2</sub>&#948;-2 and PrP in mouse cerebella</title><p>(<bold>A</bold>) DRM fractions from WT (left-hand panel), PrP Tg(WT) (middle panel) and PrP KO (right-hand panel) mouse cerebella were prepared as described in the Materials and methods section. Aliquots were resolved on 3&#8211;8% Tris/acetate (to resolve &#945;<sub>2</sub>&#948;s) or 4&#8211;12% Bis-Tris gels (to resolve PrP in the same samples), and analysed by Western blotting (WB) with relevant antibodies as indicated. The full profile is not shown, but only the fractions of the sucrose gradient corresponding to DRMs identified by the presence of flotillin-1 (fractions 4&#8211;7 harvested from the top). The anti-&#945;<sub>2</sub>&#948;-1 and anti-&#945;<sub>2</sub>&#948;-2 antibodies recognize the &#945;<sub>2</sub>-1 and &#945;<sub>2</sub>-2 moieties. (<bold>B</bold>) Aliquots of concentrated DRM fractions from WT (left-hand panel), PrP Tg(WT) (middle panel) and PrP KO (right-hand panel) cerebella were treated with PNGase F and analysed by Western blotting with the indicated antibodies. (<bold>C</bold>) DRM fractions analysed in (<bold>A</bold>) were subjected to PI-PLC treatment and Triton X-114 phase separation (see the Materials and methods section), followed by PNGase F deglycosylation. The proteins remaining in the aqueous (aq) and detergent (det) phase were then resolved on 4&#8211;12% Bis-Tris gels and analysed with the indicated antibodies. Lanes 1 and 2&#160;in each panel are from detergent phase fractions, whereas lanes 3 and 4 are from the respective aqueous phase, treated or not with PI-PLC as indicated. (<bold>D</bold>) The PrP Tg(WT) fractions from (<bold>C</bold>, middle panel) were also blotted for PrP using the 3F4 antibody. Molecular mass is shown on the right-hand side of the gels in kDa.</p></caption><graphic xlink:href="bj2013-1405i001"/></fig><p>It is well-established that PrP is GPI-anchored [<xref rid="B18" ref-type="bibr">18</xref>], and our previous findings indicate that the &#945;<sub>2</sub>&#948; subunits can form GPI-anchored proteins [<xref rid="B13" ref-type="bibr">13</xref>]. One important piece of evidence supporting this premise is that following PI-PLC treatment, both endogenous &#945;<sub>2</sub>&#948; subunits from the rat brain and heterologously expressed &#945;<sub>2</sub>&#948; proteins redistribute from the detergent phase into the aqueous phase upon Triton X-114 phase separation [<xref rid="B13" ref-type="bibr">13</xref>]. This demonstrates that PI-PLC treatment has converted the protein into a hydrophilic species, most probably by removing the bulky hydrophobic GPI anchor. To assess if the behaviour of &#945;<sub>2</sub>&#948; proteins in this phase-separation assay was affected by the presence or absence of PrP, we concentrated the DRM fractions enriched in both PrP and &#945;<sub>2</sub>&#948; and subjected them to PI-PLC treatment as described previously [<xref rid="B13" ref-type="bibr">13</xref>]. An aliquot of the initial DRM material from the three mouse genotypes, before PI-PLC treatment, was deglycosylated with PNGase F to demonstrate the presence of &#945;<sub>2</sub>&#948;-1 and &#945;<sub>2</sub>&#948;-2 (<xref ref-type="fig" rid="F1">Figure 1</xref>B).</p><p>PI-PLC treatment caused &#945;<sub>2</sub>&#948;-1 and &#945;<sub>2</sub>&#948;-2 to redistribute into the aqueous phase upon Triton X-114 phase separation in all three of the mouse genotypes tested (<xref ref-type="fig" rid="F1">Figure 1</xref>C). As a control, the PrP Tg(WT) samples were also blotted for PrP, and redistributed similarly upon PI-PLC treatment (<xref ref-type="fig" rid="F1">Figure 1</xref>D).</p><p>Importantly, the response of &#945;<sub>2</sub>&#948;-1 and &#945;<sub>2</sub>&#948;-2 to PI-PLC treatment was not affected by the absence of PrP, in the PrP KO cerebellar material (<xref ref-type="fig" rid="F1">Figure 1</xref>C). It was also not affected by the overexpression of PrP in the PrP Tg(WT) cerebellar material (<xref ref-type="fig" rid="F1">Figure 1</xref>C). These data indicate that although PrP has been reported to interact with &#945;<sub>2</sub>&#948; subunits [<xref rid="B35" ref-type="bibr">35</xref>], interaction with PrP was not responsible for the presence of &#945;<sub>2</sub>&#948; subunits in DRM fractions or their redistribution into the aqueous phase following PI-PLC cleavage of GPI-anchor sites.</p></sec><sec><title>Co-expression of PrP decreased calcium channel currents containing Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2</title><p>We then examined whether PrP would influence the ability of &#945;<sub>2</sub>&#948; to increase calcium channel currents. We expressed Ca<sub>V</sub>2.1/&#946;4 and &#945;<sub>2</sub>&#948;-2 to mimic the calcium channel combination present in cerebellar Purkinje cells, either with or without PrP. We found that PrP co-expression produced a moderate, but consistent, reduction in peak calcium channel currents at +10 mV of approximately 34%, although the currents in the presence of PrP and &#945;<sub>2</sub>&#948; remained significantly larger than those in the absence of &#945;<sub>2</sub>&#948; (<xref ref-type="fig" rid="F2">Figures 2</xref>A&#8211;<xref ref-type="fig" rid="F2">2</xref>C). The voltage-dependence of activation of the Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 currents in the presence of PrP was also significantly depolarized, compared with in its absence, although not to the same extent as in the absence of &#945;<sub>2</sub>&#948; (<xref ref-type="fig" rid="F2">Figure 2</xref>D). Similarly, the voltage-dependence of steady-state inactivation of Ca<sub>V</sub>2.2/&#946;4/&#945;<sub>2</sub>&#948;-2 was depolarized significantly in the additional presence of PrP (<xref ref-type="fig" rid="F2">Figures 2</xref>E and <xref ref-type="fig" rid="F2">2</xref>F). All these effects are indicative of a reduced enhancement by &#945;<sub>2</sub>&#948;-2 of Ca<sub>V</sub>2.1/&#946;4 calcium channel currents when PrP was co-expressed.</p><fig id="F2" position="float"><label>Figure 2</label><caption><title>Effect of PrP on Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 calcium channel currents</title><p>(<bold>A</bold>) Current&#8211;voltage (<italic>I</italic>&#8211;<italic>V</italic>) relationships for <italic>I</italic><sub>Ba</sub> recorded from tsA-201 cells expressing Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (&#9632;; <italic>n</italic>=25), Ca<sub>V</sub>2.1/&#946;4 alone (&#9675;; <italic>n</italic>=7) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (&#9651;; <italic>n</italic>=23). The ratio of cDNAs used for transfection for Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT-PrP was 3:2:2:1, with empty vector used where &#945;<sub>2</sub>&#948; or PrP was absent. (<bold>B</bold>) Examples of families of <italic>I</italic><sub>Ba</sub> current traces resulting from step potentials from &#8722;100 mV to between &#8722;30 and +15 mV in 5 mV increments for Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (top panel), Ca<sub>V</sub>2.1/&#946;4 alone (middle panel) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (bottom panel). (<bold>C</bold>) Individual peak <italic>I</italic><sub>Ba</sub> currents at +10 mV, expressed as the mean&#177;S.E.M. percentage of the control condition with WT &#945;<sub>2</sub>&#948;-2 and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (&#9632;; <italic>n</italic>=25), Ca<sub>V</sub>2.1/&#946;4 alone (&#9675;; <italic>n</italic>=7) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (&#9651;; <italic>n</italic>=23). **<italic>P</italic>&lt;0.01 and ***<italic>P</italic>&lt;0.001. (<bold>D</bold>) Voltage-dependence of activation (<italic>V</italic><sub>50</sub> activation) determined by fitting a modified Boltzmann function to the individual <italic>I</italic>&#8211;<italic>V</italic> relationships shown in (<bold>A</bold>) for Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (black bar), Ca<sub>V</sub>2.1/&#946;4 alone (white bar) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (grey bar). *<italic>P</italic>&lt;0.05 and **<italic>P</italic>&lt;0.01. (<bold>E</bold>) Steady-state inactivation curves for <italic>I</italic><sub>Ba</sub> recorded from cells expressing Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (&#9632;; <italic>n</italic>=12), Ca<sub>V</sub>2.1/&#946;4 alone (&#9675;; <italic>n</italic>=4) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (&#9651;; <italic>n</italic>=8). (<bold>F</bold>) Voltage-dependence of steady-state inactivation (<italic>V</italic><sub>50</sub> inactivation) determined by fitting a Boltzmann function to the individual steady-state inactivation relationships for the data shown in (<bold>E</bold>); Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 (black bar), Ca<sub>V</sub>2.1/&#946;4 alone (white bar) and Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2/WT PrP (grey bar). **<italic>P</italic>&lt;0.01; NS, not significant. All statistical differences were determined by one-way ANOVA and Dunnett's multiple comparison test.</p></caption><graphic xlink:href="bj2013-1405i002"/></fig></sec><sec><title>Co-expression of PrP decreased calcium channel currents containing Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1</title><p>We then examined whether PrP would also inhibit calcium channel combinations containing &#945;<sub>2</sub>&#948;-1, and tested whether any effect could be due to the demonstrated interaction at the level of the two polypeptides [<xref rid="B35" ref-type="bibr">35</xref>] or a result of lipid anchoring and co-localization in the same cholesterol-rich microdomains. We therefore expressed Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 with either WT PrP or anchorless PrP, truncated at the GPI-anchor site (&#916;GPI&#8211;PrP) [<xref rid="B38" ref-type="bibr">38</xref>]. We observed that co-expression with WT PrP reduced the peak calcium channel currents to a similar extent (39%) to that shown for the Ca<sub>V</sub>2.1/&#946;4/&#945;<sub>2</sub>&#948;-2 combination (<xref ref-type="fig" rid="F3">Figures 3</xref>A&#8211;<xref ref-type="fig" rid="F3">3</xref>C), whereas &#916;GPI&#8211;PrP had no effect on the Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 calcium channel currents (<xref ref-type="fig" rid="F3">Figures 3</xref>A&#8211;<xref ref-type="fig" rid="F3">3</xref>C). In these experiments WT PrP did not produce a significant depolarization of the voltage-dependence of activation of the currents (<xref ref-type="fig" rid="F3">Figure 3</xref>D).</p><fig id="F3" position="float"><label>Figure 3</label><caption><title>Effect of PrP constructs on Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 calcium channel currents</title><p>(<bold>A</bold>) Examples of families of <italic>I</italic><sub>Ba</sub> current traces resulting from step potentials from &#8722;90 mV to between &#8722;30 and +10 mV in 5 mV steps for Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (top panel) with WT PrP (middle panel) or with &#916;GPI&#8211;PrP (bottom panel). The ratio of cDNAs used for the transfection of Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1/PrP was 3:2:2:1, with empty vector used where &#945;<sub>2</sub>&#948; or PrP was absent. (<bold>B</bold>) <italic>I</italic>&#8211;<italic>V</italic> relationships for <italic>I</italic><sub>Ba</sub> recorded from tsA-201 cells expressing Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (&#9632;; <italic>n</italic>=28) with WT PrP (&#9650;; <italic>n</italic>=19) or with &#916;GPI&#8211;PrP (&#9651;; <italic>n</italic>=13). (<bold>C</bold>) Individual mean&#177;S.E.M. peak <italic>I</italic><sub>Ba</sub> currents at +5 mV for Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (&#9632;; <italic>n</italic>=28) with WT PrP (&#9650;; <italic>n</italic>=19) or &#916;GPI&#8211;PrP (&#9651;; <italic>n</italic>=13). **<italic>P</italic>&lt;0.01. (<bold>D</bold>) <italic>V</italic><sub>50</sub> activation for Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (black bar) with WT PrP (white bar) or with &#916;GPI&#8211;PrP (grey bar). All statistical differences were determined by one-way ANOVA and Dunnett's multiple comparison test. (<bold>E</bold> and <bold>F</bold>) Ca<sub>V</sub>2.2/&#946;1b/&#945;<sub>2</sub>&#948;-1 was expressed in <italic>Xenopus</italic> oocytes either alone or together with PrP at the ratios shown. (<bold>E</bold>) Representative current traces elicited by steps to test potentials between &#8722;25 and +10 mV in 5 mV steps from a holding potential of &#8722;100 mV for Ca<sub>V</sub>2.2/&#946;1b/&#945;<sub>2</sub>&#948;-1/PrP (1:0.25; upper panel) or Ca<sub>V</sub>2.2/&#946;1b/&#945;<sub>2</sub>&#948;-1/PrP (1:1; lower panel). The residual voltage clamp transients have been truncated. (<bold>F</bold>) Peak currents measured at +10 mV for three &#945;<sub>2</sub>&#948;-1/PrP ratios plotted as the mean&#177;S.E.M. percentage of the mean control <italic>I</italic><sub>Ba</sub> recorded in the absence of PrP in the same experiment. &#945;<sub>2</sub>&#948;-1/PrP 1:1 (black bar; <italic>n</italic>=6), &#945;<sub>2</sub>&#948;-1/PrP ratio 1:0.5 (grey bar; <italic>n</italic>=18), &#945;<sub>2</sub>&#948;-1/PrP ratio 1:0.25 (white bar; <italic>n</italic>=20) and mean normalized control for &#945;<sub>2</sub>&#948;-1&#160;in the absence of PrP (hatched bar; <italic>n</italic>=21). *<italic>P</italic>=0.016 between the individual conditions and their respective control condition performed in the same experiment as determined by Student's <italic>t</italic> test.</p></caption><graphic xlink:href="bj2013-1405i003"/></fig><p>In another expression system, <italic>Xenopus</italic> oocytes with microinjected cDNAs and where the ratio of the different constructs can be controlled accurately, the effect of PrP to reduce Ca<sub>V</sub>2.2/&#946;1b/&#945;<sub>2</sub>&#948;-1 calcium channel currents was observed at an &#945;<sub>2</sub>&#948;-1/PrP ratio of 1:1, but not at 2:1 or 4:1 (<xref ref-type="fig" rid="F3">Figures 3</xref>E and <xref ref-type="fig" rid="F3">3</xref>F), indicating that it was dependent on the amount of PrP expressed relative to &#945;<sub>2</sub>&#948;. Taken together, these results suggest that the effect of PrP to reduce calcium channel currents is concentration-dependent, and the presence of a GPI anchor on PrP may be essential for the observed reduction in the functional expression of calcium currents.</p></sec><sec><title>Membrane anchoring of both PrP and &#945;<sub>2</sub>&#948;-1 is required for calcium channel current inhibition by PrP</title><p>In order to test the importance of membrane anchoring of both &#945;<sub>2</sub>&#948;-1 and PrP on the inhibition by PrP we expressed Ca<sub>V</sub>2.1/&#946;1b with either WT &#945;<sub>2</sub>&#948;-1 or anchorless &#945;<sub>2</sub>&#948;-1 (&#945;<sub>2</sub>&#948;-1&#916;C&#8211;HA), together with either WT PrP or anchorless PrP truncated at the GPI-anchor site (&#916;GPI&#8211;PrP). We have shown previously that an anchorless form of &#945;<sub>2</sub>&#948;-1, although being mainly secreted, is still able to promote an increase in calcium channel currents compared with no &#945;<sub>2</sub>&#948;, although to a smaller extent than WT &#945;<sub>2</sub>&#948;-1 [<xref rid="B36" ref-type="bibr">36</xref>]. In the present study we obtained the surprising result, shown in <xref ref-type="fig" rid="F4">Figures 4</xref>(A)&#8211;<xref ref-type="fig" rid="F4">4</xref>(C), that, whereas WT PrP inhibited calcium channel currents in the presence of WT &#945;<sub>2</sub>&#948;-1, it did not produce any reduction in the presence of anchorless &#945;<sub>2</sub>&#948;-1&#916;C&#8211;HA (<xref ref-type="fig" rid="F4">Figure 4</xref>C). In agreement with the data shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, &#916;GPI&#8211;PrP did not produce any inhibition of calcium channel currents formed with WT &#945;<sub>2</sub>&#948;-1 (<xref ref-type="fig" rid="F4">Figure 4</xref>C). Similarly &#916;GPI&#8211;PrP did not produce any reduction in the currents formed with anchorless &#945;<sub>2</sub>&#948;-1&#916;C&#8211;HA (<xref ref-type="fig" rid="F4">Figure 4</xref>C). We found from Western blotting that the WT and truncated &#945;<sub>2</sub>&#948; and PrP species used are all well-expressed in tsA-201 cells (<xref ref-type="fig" rid="F4">Figures 4</xref>D and <xref ref-type="fig" rid="F4">4</xref>E), and lack of expression therefore could not account for the lack of effect of the truncated constructs when expressed together.</p><fig id="F4" position="float"><label>Figure 4</label><caption><title>Comparison of the effect of PrP constructs on calcium channel currents containing &#945;<sub>2</sub>&#948;-1 or anchorless &#945;<sub>2</sub>&#948;-1</title><p>(<bold>A</bold>) <italic>I-</italic>-<italic>V</italic> relationships for <italic>I</italic><sub>Ba</sub> recorded from tsA-201 cells expressing Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (&#9632;; <italic>n</italic>=16) with WT PrP (&#9650;; <italic>n</italic>=10) or &#916;GPI&#8211;PrP (&#9670;; <italic>n</italic>=14) or cells expressing Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1&#916;C alone (&#9633;; <italic>n</italic>=11) with WT PrP (&#8710;; <italic>n</italic>=13) or &#916;GPI&#8211;PrP (&#9671;; <italic>n</italic>=15). The ratio of cDNAs was the same as in <xref ref-type="fig" rid="F3">Figure 3</xref>(A). (<bold>B</bold>) Examples of families of <italic>I</italic><sub>Ba</sub> current traces resulting from step potentials from &#8722;90 mV to between &#8722;30 and +10 mV in 5 mV steps for Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 alone (top left-hand panel) or &#945;<sub>2</sub>&#948;-1&#916;C alone (top right-hand panel) with WT PrP (middle panel) or &#916;GPI&#8211;PrP (bottom panels). (<bold>C</bold>) Peak <italic>I</italic><sub>Ba</sub> currents (means&#177;S.E.M.) for the data shown in (<bold>A</bold>) for Ca<sub>V</sub>2.1/&#946;1b with &#945;<sub>2</sub>&#948;-1 (solid bars) or with &#945;<sub>2</sub>&#948;-1&#916;C (hatched bars) either alone (black bars) or with WT PrP (light grey bars), or &#916;GPI-PrP (dark grey bars). *<italic>P</italic>&lt;0.05 as determined by one-way ANOVA and Bonferroni's post-hoc test. (<bold>D</bold>) Western blot of &#945;<sub>2</sub>&#948;-1 (upper panels; 4&#8211;12% Bis-Tris gel) co-expressed (1:1) with WT PrP (left-hand lane), &#8710;GPI&#8211;PrP (middle lane) or empty vector (right-hand lane; con). PrP expression is shown in the lower panel (4&#8211;12% Bis-Tris gel). The lower expression of &#8710;GPI&#8211;PrP in the cell lysate is because much of it is secreted [<xref rid="B53" ref-type="bibr">53</xref>]. (<bold>E</bold>) Western blot of &#945;<sub>2</sub>&#948;-1&#8710;C in medium (upper panels; 3&#8211;8% Tris/acetate gel) and cell lysate (lower panels; 4&#8211;12% Bis-Tris gel) co-expressed (1:1) with PrP (left-hand panels), &#8710;GPI&#8211;PrP (middle panel) or empty vector (right-hand panels; con). In both (<bold>D</bold>) and (<bold>E</bold>), all three lanes are from the same blots from which irrelevant lanes have been excised and the molecular mass is given on the right-hand side in kDa.</p></caption><graphic xlink:href="bj2013-1405i004"/></fig><p>This result suggests either that association of the &#945;<sub>2</sub>&#948; and PrP proteins in the plasma membrane, and potentially in the same cholesterol-rich membrane microdomains, facilitated by their GPI anchoring, is essential for the inhibition of calcium currents observed or that there is competition between &#945;<sub>2</sub>&#948;-1 and PrP for the GPI-anchor intermediates, resulting in less maturation of &#945;<sub>2</sub>&#948; subunit in the presence of PrP. We therefore examined whether the effect of PrP might be related to the GPI anchor and tested the effect of an unrelated protein engineered to contain a GPI anchor (GFP&#8211;GPI). We found that co-expression of GFP&#8211;GPI markedly reduced calcium channel currents formed by Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 compared with the co-expression of cytosolic GFP, and in this experiment &#8710;GPI&#8211;PrP again had no effect (<xref ref-type="fig" rid="F5">Figure 5</xref>A). This result is in agreement with the hypothesis that overexpression of a GPI-anchored protein can produce this inhibition. We then compared the level of &#945;<sub>2</sub>&#948;-1 expression in the presence of co-expressed GFP&#8211;GPI and cytosolic GFP (<xref ref-type="fig" rid="F5">Figure 5</xref>B). In all cases substantial &#945;<sub>2</sub>&#948;-1 was co-expressed.</p><fig id="F5" position="float"><label>Figure 5</label><caption><title>Effect of GPI&#8211;GFP on Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 calcium channel currents</title><p>(<bold>A</bold>) <italic>I</italic>&#8211;<italic>V</italic> relationships for <italic>I</italic><sub>Ba</sub> recorded from tsA-201 cells expressing Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 with GFP (&#9632;; <italic>n</italic>=9), GPI&#8211;GFP (&#9650;; <italic>n</italic>=9), or GFP and &#916;GPI&#8211;PrP (&#9651;; <italic>n</italic>=6). The broken line indicates the level of <italic>I</italic><sub>Ba</sub> observed for Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 plus WT PrP from <xref ref-type="fig" rid="F3">Figure 3</xref>(B). ***<italic>P</italic>&lt;0.001 between the peak <italic>I</italic><sub>Ba</sub> when GPI&#8211;GFP was co-expressed compared with when GFP was co-expressed (Student's <italic>t</italic> test). (<bold>B</bold>) Western blot of &#945;<sub>2</sub>&#948;-1 (upper panels) co-expressed (1:1) with GFP&#8211;GPI (lane 1), GFP (lane 2) or empty vector (lane 3; con). GFP expression is shown in the lower panel. All three lanes are from the same blots from which irrelevant lanes have been excised and the molecular mass is given on the right-hand side in kDa.</p></caption><graphic xlink:href="bj2013-1405i005"/></fig></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In the present study we found that when PrP is co-expressed with Ca<sub>V</sub>2.1 calcium channels together with a &#946;-subunit and either &#945;<sub>2</sub>&#948;-1 or &#945;<sub>2</sub>&#948;-2, it produces a modest reduction in the expressed calcium channel currents. This reduction in calcium channel currents involves the membrane anchoring of PrP, as it is absent when PrP is truncated prior to its GPI-anchor site. Thus &#916;GPI&#8211;PrP did not inhibit currents formed by the expression of Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1. This result suggests that the process might involve competition for pathways associated with the GPI anchoring of PrP, which might relate to our finding that &#945;<sub>2</sub>&#948; subunits form GPI-anchored proteins [<xref rid="B13" ref-type="bibr">13</xref>]. The results of the present study reinforce that view, since native cerebellar &#945;<sub>2</sub>&#948;-1, &#945;<sub>2</sub>&#948;-2 and PrP all behave similarly following PI-PLC treatment and phase separation, being concentrated in the aqueous phase (<xref ref-type="fig" rid="F1">Figure 1</xref>), which is supportive of evidence for GPI anchoring.</p><p>We therefore utilized an &#945;<sub>2</sub>&#948;-1 subunit truncated at the predicted membrane attachment site (&#945;<sub>2</sub>&#948;-1&#916;C), which, as we have shown recently, is not an integral membrane protein [<xref rid="B36" ref-type="bibr">36</xref>]. We have characterized &#945;<sub>2</sub>&#948;-1&#916;C and found that, despite being mainly secreted, it still shows a partial ability to enhance calcium channel currents and to be associated extrinsically with the plasma membrane [<xref rid="B36" ref-type="bibr">36</xref>]. It is therefore possible that &#945;<sub>2</sub>&#948;-1 enhances calcium currents by two mechanisms, one involving a trafficking process that is still maintained by anchorless &#945;<sub>2</sub>&#948;-1&#8710;C, and another mechanism that requires its membrane anchoring, for example a process that stabilizes channel complexes in the plasma membrane.</p><p>Importantly, we also found in the present study that WT PrP does not inhibit calcium channel currents when &#945;<sub>2</sub>&#948;-1&#916;C was substituted for WT &#945;<sub>2</sub>&#948;-1. This suggested to us two possibilities. First, PrP and &#945;<sub>2</sub>&#948;-1 may compete for GPI-anchor intermediates or subsequent trafficking processes specific for GPI-anchored proteins when both are overexpressed. Secondly, the interaction between PrP and &#945;<sub>2</sub>&#948;-1 with other protein and lipid components in cholesterol-rich membrane microdomains [<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>] might be involved in the suppression of currents. Thus when either PrP or &#945;<sub>2</sub>&#948;-1 is devoid of the lipid anchor no suppression occurs.</p><p>It is possible that WT &#945;<sub>2</sub>&#948;-1 and PrP interact indirectly via an intermediary trafficking protein and compete for binding to that protein, whereas this does not occur when one of them is not membrane-anchored. Nevertheless, the additional finding that Ca<sub>V</sub>2.1/&#946;1b/&#945;<sub>2</sub>&#948;-1 currents were also inhibited by GPI&#8211;GFP (when compared with the control GFP) suggests that the presence of a GPI anchor might be an important common denominator in this process. Only approximately 150 proteins are known to be GPI-anchored, and the GPI synthetic pathway, involving multiple enzymatic steps in the ER (endoplasmic reticulum) and Golgi, is likely to have limited capacity in mammalian cells [<xref rid="B52" ref-type="bibr">52</xref>]. Overexpression of multiple GPI-anchored proteins in the same cell might lead to saturation of limited resources. Further studies will be necessary to determine whether overexpression of other GPI-anchored proteins disrupts the function of &#945;<sub>2</sub>&#948; within membrane microdomains, or possibly competes with it for GPI transamidase enzymes, GPI-anchoring intermediates or trafficking proteins subsequent to GPI anchoring. Taken together, the results of the present study provide supporting evidence that &#945;<sub>2</sub>&#948;-1 can be GPI-anchored. More generally the results point to a competitive interaction between GPI-anchored proteins for resources that determine their level of post-translational processing or expression on the plasma membrane.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We thank Wendy S. Pratt and Kanchan Chaggar for technical assistance.</p></ack><sec><title>AUTHOR CONTRIBUTION</title><p>Annette Dolphin and Roberto Chiesa conceived the study. Anita Alvarez Laviada performed the patch-clamp electrophysiology. Annette Dolphin performed electrophysiology in <italic>Xenopus</italic> oocytes. Ivan Kadurin obtained all data shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. Assunta Senatore performed the Western blotting shown in <xref ref-type="fig" rid="F3">Figures 4</xref> and <xref ref-type="fig" rid="F5">5</xref>. Roberto Chiesa supplied constructs, mouse tissue and antibodies. Annette Dolphin, Ivan Kadurin and Roberto Chiesa wrote the paper.</p></sec><sec><title>FUNDING</title><p>This work was supported by the <funding-source id="gs1">Medical Research Council</funding-source> [grant numbers <award-id rid="gs1">G0801756</award-id> and <award-id rid="gs1">G0901758</award-id> (to A.C.D.)], the <funding-source id="gs2">Wellcome Trust</funding-source> [Programme grant number <award-id rid="gs2">098360/Z/12/Z</award-id>] and the <funding-source id="gs3">Fondazione Telethon</funding-source> [grant numbers <award-id rid="gs3">TDRC00508TU</award-id> and <award-id rid="gs3">GGP12115</award-id> (to R.C.)]. A.A.-L. was supported by a <funding-source id="gs4">Biotechnology and Biological Sciences Research Council</funding-source> PhD studentship. A.S. was supported by a fellowship from the <funding-source id="gs5">Banca del Monte di Lombardia Foundation</funding-source>. R.C. is an <funding-source id="gs6">Associate Telethon Scientist</funding-source> (Dulbecco Telethon Institute, Fondazione Telethon).</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Hendrich</surname><given-names>J.</given-names></name><name><surname>Van Minh</surname><given-names>A. T.</given-names></name><name><surname>Wratten</surname><given-names>J.</given-names></name><name><surname>Douglas</surname><given-names>L.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Functional biology of the &#945;2&#948; subunits of voltage-gated calcium channels</article-title><source>Trends Pharmacol. Sci.</source><year>2007</year><volume>28</volume><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">17403543</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>D.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name></person-group><article-title>Subunit interaction sites in voltage-dependent Ca<sup>2+</sup> channels</article-title><source>Trends Neurosci.</source><year>1998</year><volume>21</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">9554724</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>&#946; Subunits of voltage-gated calcium channels</article-title><source>J. Bioeng. Biomemb.</source><year>2003</year><volume>35</volume><fpage>599</fpage><lpage>620</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pragnell</surname><given-names>M.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Tanabe</surname><given-names>T.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group><article-title>Calcium channel &#946;-subunit binds to a conserved motif in the I&#8211;II cytoplasmic linker of the &#945;<sub>1</sub>-subunit</article-title><source>Nature</source><year>1994</year><volume>368</volume><fpage>67</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">7509046</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leroy</surname><given-names>J.</given-names></name><name><surname>Richards</surname><given-names>M. S.</given-names></name><name><surname>Butcher</surname><given-names>A. J.</given-names></name><name><surname>Nieto-Rostro</surname><given-names>M.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Interaction via a key tryptophan in the I&#8211;II linker of N-type calcium channels is required for beta1 but not for palmitoylated &#946;2, implicating an additional binding site in the regulation of channel voltage-dependent properties</article-title><source>J. Neurosci.</source><year>2005</year><volume>25</volume><fpage>6984</fpage><lpage>6996</lpage><pub-id pub-id-type="pmid">16049174</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waithe</surname><given-names>D.</given-names></name><name><surname>Ferron</surname><given-names>L.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Chaggar</surname><given-names>K.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>&#946;-Subunits promote the expression of Ca<sub>v</sub>2.2 channels by reducing their proteasomal degradation</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>9598</fpage><lpage>9611</lpage><pub-id pub-id-type="pmid">21233207</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altier</surname><given-names>C.</given-names></name><name><surname>Garcia-Caballero</surname><given-names>A.</given-names></name><name><surname>Simms</surname><given-names>B.</given-names></name><name><surname>You</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Walcher</surname><given-names>J.</given-names></name><name><surname>Tedford</surname><given-names>H. W.</given-names></name><name><surname>Hermosilla</surname><given-names>T.</given-names></name><name><surname>Zamponi</surname><given-names>G. W.</given-names></name></person-group><article-title>The Ca<sub>v</sub>&#946; subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels</article-title><source>Nat. Neurosci.</source><year>2011</year><volume>14</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">21186355</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canti</surname><given-names>C.</given-names></name><name><surname>Nieto-Rostro</surname><given-names>M.</given-names></name><name><surname>Foucault</surname><given-names>I.</given-names></name><name><surname>Heblich</surname><given-names>F.</given-names></name><name><surname>Wratten</surname><given-names>J.</given-names></name><name><surname>Richards</surname><given-names>M. W.</given-names></name><name><surname>Hendrich</surname><given-names>J.</given-names></name><name><surname>Douglas</surname><given-names>L.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of &#945;2&#948; subunits is key to trafficking voltage-gated Ca<sup>2+</sup> channels</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2005</year><volume>102</volume><fpage>11230</fpage><lpage>11235</lpage><pub-id pub-id-type="pmid">16061813</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppa</surname><given-names>M.</given-names></name><name><surname>Lana</surname><given-names>B.</given-names></name><name><surname>Margas</surname><given-names>W.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name><name><surname>Ryan</surname><given-names>T. A.</given-names></name></person-group><article-title>&#945;2&#948; couples calcium channels to neurotransmitter release sites to control release probability</article-title><source>Nature</source><year>2012</year><volume>486</volume><fpage>122</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">22678293</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>J.</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group><article-title>Using exofacially tagged functional Ca<sub>v</sub>2.2 to investigate the modulation of pore subunit trafficking by auxiliary calcium channel subunits</article-title><source>58th U.S. Biophysical Society meeting</source><year>2014</year><publisher-loc>San Francisco, CA, U.S.A.</publisher-loc><comment>15&#8211;19 February 2014, Abstract 1672-Pos</comment></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodbeck</surname><given-names>J.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Courtney</surname><given-names>J.-M.</given-names></name><name><surname>Meir</surname><given-names>A.</given-names></name><name><surname>Balaguero</surname><given-names>N.</given-names></name><name><surname>Canti</surname><given-names>C.</given-names></name><name><surname>Moss</surname><given-names>F. J.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Hunt</surname><given-names>S. P.</given-names></name><etal/></person-group><article-title>The ducky mutation in <italic>Cacna2d2</italic> results in altered Purkinje cell morphology and is associated with the expression of a truncated <italic>a2d</italic>-2 protein with abnormal function</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>7684</fpage><lpage>7693</lpage><pub-id pub-id-type="pmid">11756448</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakamori</surname><given-names>M.</given-names></name><name><surname>Mikala</surname><given-names>G.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name></person-group><article-title>Auxiliary subunits operate as a molecular switch in determining gating behaviour of the unitary N-type Ca<sup>2+</sup> channel current in <italic>Xenopus</italic> oocytes</article-title><source>J. Physiol.</source><year>1999</year><volume>517</volume><fpage>659</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">10358108</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Kadurin</surname><given-names>I.</given-names></name><name><surname>Alvarez-Laviada</surname><given-names>A.</given-names></name><name><surname>Douglas</surname><given-names>L.</given-names></name><name><surname>Nieto-Rostro</surname><given-names>M.</given-names></name><name><surname>Bauer</surname><given-names>C. S.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>The &#945;2&#948; subunits of voltage-gated calcium channels form GPI-anchored proteins, a post-translational modification essential for function</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2010</year><volume>107</volume><fpage>1654</fpage><lpage>1659</lpage><pub-id pub-id-type="pmid">20080692</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurnett</surname><given-names>C. A.</given-names></name><name><surname>De Waard</surname><given-names>M.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group><article-title>Dual function of the voltage-dependent Ca<sup>2+</sup> channel &#945;2&#948; subunit in current stimulation and subunit interaction</article-title><source>Neuron</source><year>1996</year><volume>16</volume><fpage>431</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">8789958</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group><article-title>Structure and regulation of voltage-gated Ca<sup>2+</sup> channels</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2000</year><volume>16</volume><fpage>521</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">11031246</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arikkath</surname><given-names>J.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group><article-title>Auxiliary subunits: essential components of the voltage-gated calcium channel complex</article-title><source>Curr. Opin. Neurobiol.</source><year>2003</year><volume>13</volume><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">12850214</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>S. D.</given-names></name><name><surname>Sharp</surname><given-names>A. H.</given-names></name><name><surname>Kahl</surname><given-names>S. D.</given-names></name><name><surname>Vedvick</surname><given-names>T. S.</given-names></name><name><surname>Harpold</surname><given-names>M. M.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group><article-title>Structural characterization of the dihydropyridine-sensitive calcium channel &#945;<sub>2</sub>-subunit and the associated &#948; peptides</article-title><source>J. Biol. Chem.</source><year>1991</year><volume>266</volume><fpage>3287</fpage><lpage>3293</lpage><pub-id pub-id-type="pmid">1847144</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>N.</given-names></name><name><surname>Borchelt</surname><given-names>D. R.</given-names></name><name><surname>Hsiao</surname><given-names>K.</given-names></name><name><surname>Prusiner</surname><given-names>S. B.</given-names></name></person-group><article-title>Scrapie prion protein contains a phosphatidylinositol glycolipid</article-title><source>Cell</source><year>1987</year><volume>51</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">2444340</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collinge</surname><given-names>J.</given-names></name></person-group><article-title>Molecular neurology of prion disease</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2005</year><volume>76</volume><fpage>906</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">15965195</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biasini</surname><given-names>E.</given-names></name><name><surname>Turnbaugh</surname><given-names>J. A.</given-names></name><name><surname>Unterberger</surname><given-names>U.</given-names></name><name><surname>Harris</surname><given-names>D. A.</given-names></name></person-group><article-title>Prion protein at the crossroads of physiology and disease</article-title><source>Trends Neurosci.</source><year>2012</year><volume>35</volume><fpage>92</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">22137337</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueler</surname><given-names>H.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Lang</surname><given-names>Y.</given-names></name><name><surname>Bluethmann</surname><given-names>H.</given-names></name><name><surname>Lipp</surname><given-names>H. P.</given-names></name><name><surname>Dearmond</surname><given-names>S. J.</given-names></name><name><surname>Prusiner</surname><given-names>S. B.</given-names></name><name><surname>Aguet</surname><given-names>M.</given-names></name><name><surname>Weissmann</surname><given-names>C.</given-names></name></person-group><article-title>Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein</article-title><source>Nature</source><year>1992</year><volume>356</volume><fpage>577</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">1373228</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>A. D.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name></person-group><article-title>The prion protein knockout mouse: a phenotype under challenge</article-title><source>Prion</source><year>2007</year><volume>1</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">19164918</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouillet-Richard</surname><given-names>S.</given-names></name><name><surname>Ermonval</surname><given-names>M.</given-names></name><name><surname>Chebassier</surname><given-names>C.</given-names></name><name><surname>Laplanche</surname><given-names>J. L.</given-names></name><name><surname>Lehmann</surname><given-names>S.</given-names></name><name><surname>Launay</surname><given-names>J. M.</given-names></name><name><surname>Kellermann</surname><given-names>O.</given-names></name></person-group><article-title>Signal transduction through prion protein</article-title><source>Science</source><year>2000</year><volume>289</volume><fpage>1925</fpage><lpage>1928</lpage><pub-id pub-id-type="pmid">10988071</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viles</surname><given-names>J. H.</given-names></name><name><surname>Cohen</surname><given-names>F. E.</given-names></name><name><surname>Prusiner</surname><given-names>S. B.</given-names></name><name><surname>Goodin</surname><given-names>D. B.</given-names></name><name><surname>Wright</surname><given-names>P. E.</given-names></name><name><surname>Dyson</surname><given-names>H. J.</given-names></name></person-group><article-title>Copper binding to the prion protein: structural implications of four identical cooperative binding sites</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1999</year><volume>96</volume><fpage>2042</fpage><lpage>2047</lpage><pub-id pub-id-type="pmid">10051591</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collinge</surname><given-names>J.</given-names></name><name><surname>Whittington</surname><given-names>M. A.</given-names></name><name><surname>Sidle</surname><given-names>K. C.</given-names></name><name><surname>Smith</surname><given-names>C. J.</given-names></name><name><surname>Palmer</surname><given-names>M. S.</given-names></name><name><surname>Clarke</surname><given-names>A. R.</given-names></name><name><surname>Jefferys</surname><given-names>J. G.</given-names></name></person-group><article-title>Prion protein is necessary for normal synaptic function</article-title><source>Nature</source><year>1994</year><volume>370</volume><fpage>295</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">8035877</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname><given-names>J.</given-names></name><name><surname>Baumann</surname><given-names>F.</given-names></name><name><surname>Tiberi</surname><given-names>C.</given-names></name><name><surname>Wessig</surname><given-names>C.</given-names></name><name><surname>Fischer</surname><given-names>H.</given-names></name><name><surname>Schwarz</surname><given-names>P.</given-names></name><name><surname>Steele</surname><given-names>A. D.</given-names></name><name><surname>Toyka</surname><given-names>K. V.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name><name><surname>Weis</surname><given-names>J.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name></person-group><article-title>Axonal prion protein is required for peripheral myelin maintenance</article-title><source>Nat. Neurosci.</source><year>2010</year><volume>13</volume><fpage>310</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">20098419</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prusiner</surname><given-names>S. B.</given-names></name></person-group><article-title>Prions</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1998</year><volume>95</volume><fpage>13363</fpage><lpage>13383</lpage><pub-id pub-id-type="pmid">9811807</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallucci</surname><given-names>G.</given-names></name><name><surname>Dickinson</surname><given-names>A.</given-names></name><name><surname>Linehan</surname><given-names>J.</given-names></name><name><surname>Klohn</surname><given-names>P. C.</given-names></name><name><surname>Brandner</surname><given-names>S.</given-names></name><name><surname>Collinge</surname><given-names>J.</given-names></name></person-group><article-title>Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>871</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">14593181</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueler</surname><given-names>H.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name><name><surname>Sailer</surname><given-names>A.</given-names></name><name><surname>Greiner</surname><given-names>R. A.</given-names></name><name><surname>Autenried</surname><given-names>P.</given-names></name><name><surname>Aguet</surname><given-names>M.</given-names></name><name><surname>Weissmann</surname><given-names>C.</given-names></name></person-group><article-title>Mice devoid of PrP are resistant to scrapie</article-title><source>Cell</source><year>1993</year><volume>73</volume><fpage>1339</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">8100741</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandner</surname><given-names>S.</given-names></name><name><surname>Isenmann</surname><given-names>S.</given-names></name><name><surname>Raeber</surname><given-names>A.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Sailer</surname><given-names>A.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Marino</surname><given-names>S.</given-names></name><name><surname>Weissmann</surname><given-names>C.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name></person-group><article-title>Normal host prion protein necessary for scrapie-induced neurotoxicity</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">8552188</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutishauser</surname><given-names>D.</given-names></name><name><surname>Mertz</surname><given-names>K. D.</given-names></name><name><surname>Moos</surname><given-names>R.</given-names></name><name><surname>Brunner</surname><given-names>E.</given-names></name><name><surname>Rulicke</surname><given-names>T.</given-names></name><name><surname>Calella</surname><given-names>A. M.</given-names></name><name><surname>Aguzzi</surname><given-names>A.</given-names></name></person-group><article-title>The comprehensive native interactome of a fully functional tagged prion protein</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e4446</fpage><pub-id pub-id-type="pmid">19209230</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Douglas</surname><given-names>L.</given-names></name><name><surname>Hendrich</surname><given-names>J.</given-names></name><name><surname>Wratten</surname><given-names>J.</given-names></name><name><surname>Tran-Van-Minh</surname><given-names>A.</given-names></name><name><surname>Foucault</surname><given-names>I.</given-names></name><name><surname>Koch</surname><given-names>D.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Saibil</surname><given-names>H.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>The calcium channel &#945;2&#948;-2 subunit partitions with Ca<sub>V</sub>2.1&#160;in lipid rafts in cerebellum: implications for localization and function</article-title><source>J. Neurosci.</source><year>2006</year><volume>26</volume><fpage>8748</fpage><lpage>8757</lpage><pub-id pub-id-type="pmid">16928863</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D. R.</given-names></name><name><surname>Whitehouse</surname><given-names>I. J.</given-names></name><name><surname>Hooper</surname><given-names>N. M.</given-names></name></person-group><article-title>Glypican-1 mediates both prion protein lipid raft association and disease isoform formation</article-title><source>PLoS Pathog.</source><year>2009</year><volume>5</volume><fpage>e1000666</fpage><pub-id pub-id-type="pmid">19936054</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfrink</surname><given-names>K.</given-names></name><name><surname>Nagel-Steger</surname><given-names>L.</given-names></name><name><surname>Riesner</surname><given-names>D.</given-names></name></person-group><article-title>Interaction of the cellular prion protein with raft-like lipid membranes</article-title><source>Biol. Chem.</source><year>2007</year><volume>388</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">17214553</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senatore</surname><given-names>A.</given-names></name><name><surname>Colleoni</surname><given-names>S.</given-names></name><name><surname>Verderio</surname><given-names>C.</given-names></name><name><surname>Restelli</surname><given-names>E.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Condliffe</surname><given-names>S.</given-names></name><name><surname>Bertani</surname><given-names>I.</given-names></name><name><surname>Mantovani</surname><given-names>S.</given-names></name><name><surname>Canovi</surname><given-names>M.</given-names></name><name><surname>Micotti</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Mutant prion protein suppresses glutamatergic neurotrasmission in cerebellar granule neurons by impairing membrane delivery of voltage-gated calcium channel &#945;2&#948;-1 subunit</article-title><source>Neuron</source><year>2012</year><volume>74</volume><fpage>300</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">22542184</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadurin</surname><given-names>I.</given-names></name><name><surname>Alvarez-Laviada</surname><given-names>A.</given-names></name><name><surname>Ng</surname><given-names>S. F.</given-names></name><name><surname>Walker-Gray</surname><given-names>R.</given-names></name><name><surname>D&#8217;Arco</surname><given-names>M.</given-names></name><name><surname>Fadel</surname><given-names>M. G.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Calcium currents are enhanced by &#945;2&#948;-1 lacking its membrane anchor</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>1287</volume><fpage>33554</fpage><lpage>33566</lpage><pub-id pub-id-type="pmid">22869375</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlinson</surname><given-names>W. J.</given-names></name><name><surname>Stea</surname><given-names>A.</given-names></name><name><surname>Bourinet</surname><given-names>E.</given-names></name><name><surname>Charnet</surname><given-names>P.</given-names></name><name><surname>Nargeot</surname><given-names>J.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name></person-group><article-title>Functional properties of a neuronal class C L-type calcium channel</article-title><source>Neuropharmacology</source><year>1993</year><volume>32</volume><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">8107966</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>R. S.</given-names></name><name><surname>Harris</surname><given-names>D. A.</given-names></name></person-group><article-title>Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>45960</fpage><lpage>45968</lpage><pub-id pub-id-type="pmid">12933795</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cormack</surname><given-names>B. P.</given-names></name><name><surname>Valdivia</surname><given-names>R. H.</given-names></name><name><surname>Falkow</surname><given-names>S.</given-names></name></person-group><article-title>FACS-optimized mutants of the green fluorescent protein (GFP)</article-title><source>Gene</source><year>1996</year><volume>173</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">8707053</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>B. J.</given-names></name><name><surname>Kenworthy</surname><given-names>A. K.</given-names></name><name><surname>Polishchuk</surname><given-names>R. S.</given-names></name><name><surname>Lodge</surname><given-names>R.</given-names></name><name><surname>Roberts</surname><given-names>T. H.</given-names></name><name><surname>Hirschberg</surname><given-names>K.</given-names></name><name><surname>Phair</surname><given-names>R. D.</given-names></name><name><surname>Lippincott-Schwartz</surname><given-names>J.</given-names></name></person-group><article-title>Rapid cycling of lipid raft markers between the cell surface and Golgi complex</article-title><source>J. Cell Biol.</source><year>2001</year><volume>153</volume><fpage>529</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">11331304</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Heblich</surname><given-names>F.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Butcher</surname><given-names>A. J.</given-names></name><name><surname>Leroy</surname><given-names>J.</given-names></name><name><surname>Bertaso</surname><given-names>F.</given-names></name><name><surname>Pratt</surname><given-names>W. S.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response</article-title><source>J. Neurosci.</source><year>2004</year><volume>24</volume><fpage>5400</fpage><lpage>5409</lpage><pub-id pub-id-type="pmid">15190113</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiesa</surname><given-names>R.</given-names></name><name><surname>Piccardo</surname><given-names>P.</given-names></name><name><surname>Ghetti</surname><given-names>B.</given-names></name><name><surname>Harris</surname><given-names>D. A.</given-names></name></person-group><article-title>Neurological illness in transgenic mice expressing a prion protein with an insertional mutation</article-title><source>Neuron</source><year>1998</year><volume>21</volume><fpage>1339</fpage><lpage>1351</lpage><pub-id pub-id-type="pmid">9883727</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordier</surname><given-names>C.</given-names></name></person-group><article-title>Phase separation of integral membrane proteins in Triton X-114 solution</article-title><source>J. Biol. Chem.</source><year>1981</year><volume>256</volume><fpage>1604</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">6257680</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>J.</given-names></name><name><surname>Balaguero</surname><given-names>N.</given-names></name><name><surname>Mione</surname><given-names>M.</given-names></name><name><surname>Ackerman</surname><given-names>S. L.</given-names></name><name><surname>Letts</surname><given-names>V. A.</given-names></name><name><surname>Brodbeck</surname><given-names>J.</given-names></name><name><surname>Canti</surname><given-names>C.</given-names></name><name><surname>Meir</surname><given-names>A.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Kusumi</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the <italic>Cacna2d2</italic> gene and decreased calcium channel current in cerebellar Purkinje cells</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>6095</fpage><lpage>6104</lpage><pub-id pub-id-type="pmid">11487633</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>S.</given-names></name><name><surname>Harris</surname><given-names>D. A.</given-names></name></person-group><article-title>A mutant prion protein displays an aberrant membrane association when expressed in cultured cells</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>24589</fpage><lpage>24597</lpage><pub-id pub-id-type="pmid">7592679</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berrow</surname><given-names>N. S.</given-names></name><name><surname>Brice</surname><given-names>N. L.</given-names></name><name><surname>Tedder</surname><given-names>I.</given-names></name><name><surname>Page</surname><given-names>K.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Properties of cloned rat a1A calcium channels transiently expressed in the COS-7 cell line</article-title><source>Eur. J. Neurosci.</source><year>1997</year><volume>9</volume><fpage>739</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">9153580</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>V.</given-names></name><name><surname>Berrow</surname><given-names>N. S.</given-names></name><name><surname>Fitzgerald</surname><given-names>E. M.</given-names></name><name><surname>Brickley</surname><given-names>K.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Inhibition of the interaction of G protein G<sub>o</sub> with calcium channels by the calcium channel &#946;-subunit in rat neurones</article-title><source>J. Physiol.</source><year>1995</year><volume>485</volume><fpage>365</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">7666364</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canti</surname><given-names>C.</given-names></name><name><surname>Davies</surname><given-names>A.</given-names></name><name><surname>Berrow</surname><given-names>N. S.</given-names></name><name><surname>Butcher</surname><given-names>A. J.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Evidence for two concentration-dependent processes for &#946; subunit effects on a1B calcium channels</article-title><source>Biophys. J.</source><year>2001</year><volume>81</volume><fpage>1439</fpage><lpage>1451</lpage><pub-id pub-id-type="pmid">11509358</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canti</surname><given-names>C.</given-names></name><name><surname>Page</surname><given-names>K. M.</given-names></name><name><surname>Stephens</surname><given-names>G. J.</given-names></name><name><surname>Dolphin</surname><given-names>A. C.</given-names></name></person-group><article-title>Identification of residues in the N-terminus of a1B critical for inhibition of the voltage-dependent calcium channel by Gbg</article-title><source>J. Neurosci.</source><year>1999</year><volume>19</volume><fpage>6855</fpage><lpage>6864</lpage><pub-id pub-id-type="pmid">10436043</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuermer</surname><given-names>C. A.</given-names></name></person-group><article-title>Reggie/flotillin and the targeted delivery of cargo</article-title><source>J. Neurochem.</source><year>2011</year><volume>116</volume><fpage>708</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">21214550</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>N. M.</given-names></name></person-group><article-title>Glypican-1 facilitates prion conversion in lipid rafts</article-title><source>J. Neurochem.</source><year>2011</year><volume>116</volume><fpage>721</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">20681952</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>M.</given-names></name><name><surname>Kinoshita</surname><given-names>T.</given-names></name></person-group><article-title>Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins</article-title><source>FEBS Lett.</source><year>2010</year><volume>584</volume><fpage>1670</fpage><lpage>1677</lpage><pub-id pub-id-type="pmid">19883648</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campana</surname><given-names>V.</given-names></name><name><surname>Caputo</surname><given-names>A.</given-names></name><name><surname>Sarnataro</surname><given-names>D.</given-names></name><name><surname>Paladino</surname><given-names>S.</given-names></name><name><surname>Tivodar</surname><given-names>S.</given-names></name><name><surname>Zurzolo</surname><given-names>C.</given-names></name></person-group><article-title>Characterization of the properties and trafficking of an anchorless form of the prion protein</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>22747</fpage><lpage>22756</lpage><pub-id pub-id-type="pmid">17556367</pub-id></element-citation></ref></ref-list></back></article>